Product image of TEZSPIRE 210mg (Tezepelumab (Genetical Recombination)) 210mg/1.91ml Syringe supplied by GNH India

TEZSPIRE 210mg

Active Ingredient:
Tezepelumab (Genetical Recombination)
Form:
Syringe
Brand:
TEZSPIRE 210mg
Origin:
Japan

TEZSPIRE 210mg (Tezepelumab (Genetical Recombination) Syringe) 210mg/1.91ml

TEZSPIRE 210mg (tezepelumab) is a prescription injection for severe asthma maintenance. This genetically recombinant monoclonal antibody helps reduce asthma attacks in adults and children 12+. Store between 2–8°C to maintain potency.

Strength

210mg/1.91ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

AstraZeneca K.K.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • TEZSPIRE 210mg is used to prevent severe asthma attacks in patients with uncontrolled symptoms despite other treatments. It is designed for those with a history of exacerbations, offering an add-on therapy option. This medication targets specific pathways to help manage persistent airway inflammation associated with asthma.

Side Effects

  • TEZSPIRE 210mg works by blocking a protein involved in asthma inflammation, which may reduce the frequency of flare-ups over time. Users may notice fewer urgent care visits or hospitalizations related to breathing difficulties. Individual responses vary based on condition severity and treatment adherence.

Precautions & Warnings

  • TEZSPIRE 210mg should be stored refrigerated between 2–8°C and protected from light. Avoid freezing or shaking the syringe. Before use, inspect for particles or discoloration; discard if present. Keep out of reach of children and pets. Consult a healthcare provider if pregnant, breastfeeding, or planning pregnancy.

Avoid Interactions

  • TEZSPIRE 210mg has not been studied with all medications, but no major drug interactions have been reported. Live vaccines should be avoided during treatment due to potential immune response interference. Always inform healthcare providers about current medications, including over-the-counter and supplements, before starting this therapy.

Frequently Asked Questions

TEZSPIRE 210mg is used to reduce severe asthma attacks in adults and children 12+ with uncontrolled symptoms.

TEZSPIRE 210mg is given as a subcutaneous injection, typically by a healthcare professional.

Consult a doctor before using TEZSPIRE 210mg if pregnant, breastfeeding, or planning pregnancy.

Common effects may include headache, sore throat, or injection site reactions.

Store TEZSPIRE 210mg between 2–8°C and protect from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tezepelumab (Genetical Recombination)

TEZSPIRE 210mg/1.91ml

TEZSPIRE 210mg/1.91ml

210mg/1.91ml PFS

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT